Weill Cornell Medicine Courses and Meetings

Event

Spine Tumor Seminar 2021

presented by Weill Cornell Medicine Courses and Meetings

35 others would like to attend.

Register Now

Notification icon Thursday, September 30, 2021 9 AM - 12:30 PM America/New_York

Event info

Specialists from Weill Cornell Medicine and New York-Presbyterian Hospital and affiliates share state-of-the-art treatment paradigms for patients with spinal tumors (metastatic as well as primary). The seminar covers surgical and nonsurgical options, including leading-edge minimally invasive approaches. Providers representing neurological surgery, neuro-oncology, medical and radiation oncology, neuroradiology, and pain anesthesia will be presenting their work.

TARGETED AUDIENCE

This CME course is intended for any clinical providers who encounter spine tumor patients in their practice, including neurosurgeons, radiation oncologists, medical oncologists, neuro-oncologists, neuroradiologists, and pain management specialists.

EDUCATIONAL OBJECTIVES

By the conclusion of this activity, participants should be able to:

  • Identify surgical options for metastatic and primary spine tumors
  • Present data on the practice of radiation therapy and systemic therapy in the treatment of spine tumors
  • Recognize opportunities for multidisciplinary collaborations in spine tumor treatment

ACCREDITATION

Weill Cornell Medical College is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Weill Cornell Medical College designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.

Faculty
  • Susan Pannullo

    Course Director

  • Kai-Ming Fu

    Course Director

  • Michael Virk

    Course Director

Course Syllabus

Click HERE to view the syllabus

35 others would like to attend.

Register Now


0 Comments
Login to view comments. Click here to Login